Ocean Biomedical Stock Price, News & Analysis
Company Description
Ocean Biomedical (OTC Link: OCEAW) is a publicly traded research and development in biotechnology company in the Pharmaceutical Preparations sector.
OCEAW stock has declined 98.1% over the past year. Shares last traded at $0.0005.
On a trailing twelve-month basis, Ocean Biomedical reported net income of -$9.5M and diluted earnings per share of $-0.34.
This page provides a comprehensive overview of OCEAW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ocean Biomedical (OCEAW) stock last traded at $0.0005. Over the past 12 months, the stock has lost 98.1%.
Latest News
Ocean Biomedical has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. View all OCEAW news →
SEC Filings
Financial Highlights
operating income reached -$3.8M, and net income was -$9.5M. Diluted earnings per share stood at $-0.34. The company generated -$4.2M in operating cash flow. With a current ratio of 0.02, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Ocean Biomedical (OCEAW) currently stands at 1.2 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 29.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Ocean Biomedical (OCEAW) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
OCEAW Company Profile & Sector Positioning
Ocean Biomedical (OCEAW) operates in the Research and Development in Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.